The role of DNA methylation modifiers in shaping the hematopoietic differentiation topology

DNA甲基化修饰剂在塑造造血分化拓扑中的作用

基本信息

  • 批准号:
    10308704
  • 负责人:
  • 金额:
    $ 49.34万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-02-01 至 2023-06-30
  • 项目状态:
    已结题

项目摘要

Hematopoietic differentiation is a stochastic process that delivers multiple distinct cell types at deterministically fixed frequencies. These opposites are reconciled through a topological representation of differentiation: even if the fate decision of each individual stem cell is stochastic, the shape of the landscape will determine the frequencies of the differentiated populations. However, how is the differentiation topology encoded? DNA methylation (DNAme) may be a key contributor to shaping the differentiation topology. DNAme is the most stably inherited epigenetic mark and therefore a strong candidate for encoding topological information. Moreover, clonal hematopoiesis in humans, a state that constitutes a significant topological disruption, often involves somatic mutations in modifiers of DNAme, including Dnmt3a, Tet2 and Idh2. To study how DNA methylation reshapes the differentiation topology we preformed single-cell RNAseq of >50,000 bone marrow progenitors from Tet2, Idh2, Dnmt3a mutated and wildtype mice. Tet2 knockout showed a decrease in erythroid-committed progenitors, and increase in monocyte-committed progenitors. Notably, this erythroid vs. monocyte fate-decision skew is caused by disruption in priming of early, uncommitted HSCs. Moreover, Dnmt3a deletion, which causes the opposite effect on methylation (hypomethylation), also results in opposite topological skews. This raises the question of what is the mechanistic link between stochastic genome-wide DNAme changes and deterministic topology skews (e.g. monocyte vs. erythroid). We hypothesize that genome-wide DNAme gain or loss may affect fate-decision through inherent biases in the TF motif CpG enrichment. Indeed, our analysis across lineage-defining transcription factor (TF) binding motifs uncovered that erythroid motifs show a marked enrichment in CpG content, compared with monocytic motifs. To further explore this hypothesis, we will examine the impact of DNAme of TF motifs on HSC priming, using two novel complementary approaches. First, ATAC-seq coupled with bisulfite sequencing will simultaneously study the sites of open chromatin critical to priming together with their methylation state. Second, to directly link DNAme and the transcriptional state of HSCs, we will apply joint single-cell bisulfite sequencing and RNAseq, to evaluate, at the single cell level, the interplay between TF binding motif DNAme and priming. To further define the impact of motif DNAme on TF binding, we will evaluate erythroid and monocytic TF binding in relation to DNAme using ChIP-bisulfite-seq. To functionally examine the impact of diffuse binding motif DNAme changes, we will apply epigenetic editing with guide RNAs targeting the binding motif itself. Finally, to examine this phenomenon in human HSC differentiation, we will apply our novel single-cell muti- omics platforms to jointly capture single-cell methylome, transcriptone and genotype. Thus, we will compare within the same individual with clonal hematopoiesis, the differentiation topology of mutant vs. wildtype HSCs, and define the role of DNAme in reshaping HSC differentiation in humans.
造血分化是一个随机的过程,它确定性地提供多种不同的细胞类型。 固定频率。这些对立面通过一种分化的拓扑表示来协调:EVEN 如果每个干细胞的命运决定是随机的,那么地形的形状将决定 分化种群的频率。但是,差异拓扑是如何编码的? DNA甲基化(DNAME)可能是形成分化拓扑结构的关键因素。DNAME是 最稳定遗传的表观遗传标记,因此是编码拓扑信息的有力候选者。 此外,人类的克隆性造血,一种构成重大拓扑破坏的状态,通常 涉及DNAME修饰物的体细胞突变,包括DNMT3A、TET2和IDH2。 为了研究DNA甲基化如何重塑分化拓扑结构,我们进行了单细胞RNAseq >来自TET2、IDH2、DNMT3A突变和野生型小鼠的50,000个骨髓祖细胞。TET2淘汰赛结果显示 红系祖细胞数量减少,单核细胞祖细胞数量增加。值得注意的是,这 红系与单核细胞命运的决定偏差是由于早期未确定的造血干细胞启动中断所致。 此外,DNMT3A缺失会对甲基化(低甲基化)产生相反的影响,也会导致 相反的拓扑偏斜。这就提出了这样一个问题:随机和随机之间的机械联系是什么? 全基因组的DNAME变化和确定性的拓扑偏斜(例如单核细胞与红系)。 我们假设全基因组DNAME的获得或丢失可能通过在基因组中的固有偏见来影响命运决定 Tf基序CpG富集区。事实上,我们对谱系定义转录因子(TF)结合基序的分析 研究发现,与单核细胞相比,红系细胞的CpG含量显著增加。 为了进一步探索这一假设,我们将检查Tf基序的DNAME对HSC启动的影响,使用 两种新的互补方法。首先,ATAC-SEQ与亚硫酸氢盐测序将同时进行 研究开放染色质对启动至关重要的位置及其甲基化状态。第二,要直接对接 DNAME和HSCs的转录状态,我们将应用联合单细胞亚硫酸氢盐测序和RNAseq, 在单细胞水平上,评估Tf结合基序DNAME和启动之间的相互作用。 为了进一步确定基序DNAME对转铁蛋白结合的影响,我们将评估红系和单核细胞转铁蛋白 使用芯片-亚硫酸氢盐-顺序与DNAME相关的绑定。从功能上检查漫反射绑定的影响 如果基序DNAME发生变化,我们将使用针对结合基序本身的引导RNA进行表观遗传编辑。 最后,为了研究人类HSC分化中的这一现象,我们将应用我们的新的单细胞多细胞。 联合捕获单细胞甲基组、转录本和基因的组学平台。因此,我们将比较 在同一个克隆造血的个体中,突变型和野生型HSCs的分化拓扑结构, 并确定DNAME在重塑人类HSC分化中的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dan Landau其他文献

Dan Landau的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Dan Landau', 18)}}的其他基金

Single-Cell Multi-omics to Link Clonal Mosaicism (CM) Genotypes with Chromatin, Epigenomic, Transcriptomic and Protein Phenotypes
单细胞多组学将克隆嵌合 (CM) 基因型与染色质、表观基因组、转录组和蛋白质表型联系起来
  • 批准号:
    10662879
  • 财政年份:
    2023
  • 资助金额:
    $ 49.34万
  • 项目类别:
Genome-wide mutational integration for ultra-sensitive plasma tumor burden monitoring in immunotherapy
全基因组突变整合用于免疫治疗中超灵敏血浆肿瘤负荷监测
  • 批准号:
    10344658
  • 财政年份:
    2022
  • 资助金额:
    $ 49.34万
  • 项目类别:
Expanding the GoT toolkit to link single-cell clonal genotypes with protein, transcriptomic, epigenomic and spatial phenotypes
扩展 GoT 工具包,将单细胞克隆基因型与蛋白质、转录组、表观基因组和空间表型联系起来
  • 批准号:
    10698112
  • 财政年份:
    2022
  • 资助金额:
    $ 49.34万
  • 项目类别:
Genome-wide mutational integration for ultra-sensitive plasma tumor burden monitoring in immunotherapy
全基因组突变整合用于免疫治疗中超灵敏血浆肿瘤负荷监测
  • 批准号:
    10631872
  • 财政年份:
    2022
  • 资助金额:
    $ 49.34万
  • 项目类别:
Center for Integrated Cellular Analysis - Alanna Fields
综合细胞分析中心 - Alanna Fields
  • 批准号:
    10839068
  • 财政年份:
    2020
  • 资助金额:
    $ 49.34万
  • 项目类别:
Center for Integrated Cellular Analysis - Lina Habba
综合细胞分析中心 - Lina Habba
  • 批准号:
    10839082
  • 财政年份:
    2020
  • 资助金额:
    $ 49.34万
  • 项目类别:
Center for Integrated Cellular Analysis - Salma Amin
综合细胞分析中心 - Salma Amin
  • 批准号:
    10839076
  • 财政年份:
    2020
  • 资助金额:
    $ 49.34万
  • 项目类别:
Center for Integrated Cellular Analysis - Stephanie Figueroa Reyes
综合细胞分析中心 - Stephanie Figueroa Reyes
  • 批准号:
    10839077
  • 财政年份:
    2020
  • 资助金额:
    $ 49.34万
  • 项目类别:
Center for Integrated Cellular Analysis
综合细胞分析中心
  • 批准号:
    10596597
  • 财政年份:
    2020
  • 资助金额:
    $ 49.34万
  • 项目类别:
Center for Integrated Cellular Analysis - Andrew Brown
综合细胞分析中心 - 安德鲁·布朗
  • 批准号:
    10839072
  • 财政年份:
    2020
  • 资助金额:
    $ 49.34万
  • 项目类别:

相似海外基金

Efficacy of MAT2A inhibitor to gastric cancer relating to aberrant DNA methylation
MAT2A 抑制剂对与异常 DNA 甲基化相关的胃癌的疗效
  • 批准号:
    21K20791
  • 财政年份:
    2021
  • 资助金额:
    $ 49.34万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Aberrant DNA Methylation Underlying Prenatal Exposures and Increased Newborn and Childhood Adiposity
异常 DNA 甲基化是产前暴露和新生儿和儿童肥胖增加的基础
  • 批准号:
    10318930
  • 财政年份:
    2019
  • 资助金额:
    $ 49.34万
  • 项目类别:
Aberrant DNA Methylation Underlying Prenatal Exposures and Increased Newborn and Childhood Adiposity
异常 DNA 甲基化是产前暴露和新生儿和儿童肥胖增加的基础
  • 批准号:
    10543751
  • 财政年份:
    2019
  • 资助金额:
    $ 49.34万
  • 项目类别:
Aberrant DNA Methylation Underlying Prenatal Exposures and Increased Newborn and Childhood Adiposity
异常 DNA 甲基化是产前暴露和新生儿和儿童肥胖增加的基础
  • 批准号:
    10078610
  • 财政年份:
    2019
  • 资助金额:
    $ 49.34万
  • 项目类别:
Risk prediction and early detection of colorectal cancer by aberrant DNA methylation in bowel lavage fluid
通过肠灌洗液中异常 DNA 甲基化进行结直肠癌风险预测和早期检测
  • 批准号:
    18K15325
  • 财政年份:
    2018
  • 资助金额:
    $ 49.34万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Aberrant DNA methylation analysis and development of highly specific risk markers in HTLV-1-related diseases
HTLV-1 相关疾病的异常 DNA 甲基化分析和高度特异性风险标记的开发
  • 批准号:
    18K07267
  • 财政年份:
    2018
  • 资助金额:
    $ 49.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Stratification of gastric cancer and identification of molecular mechanism of gastric tumorigenesis based on aberrant DNA methylation profile
基于异常DNA甲基化谱的胃癌分层及胃癌发生的分子机制鉴定
  • 批准号:
    16H05412
  • 财政年份:
    2016
  • 资助金额:
    $ 49.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Aberrant DNA methylation and parenting behavior associated with caregiver maltreatment
与照顾者虐待相关的异常 DNA 甲基化和养育行为
  • 批准号:
    9080464
  • 财政年份:
    2016
  • 资助金额:
    $ 49.34万
  • 项目类别:
Aberrant DNA methylation and parenting behavior associated with caregiver maltreatment
与照顾者虐待相关的异常 DNA 甲基化和养育行为
  • 批准号:
    9356526
  • 财政年份:
    2016
  • 资助金额:
    $ 49.34万
  • 项目类别:
The study of novel diagnosis and treatment for endometrial cancer targeting aberrant DNA methylation
针对异常DNA甲基化的子宫内膜癌新诊断和治疗研究
  • 批准号:
    16K11154
  • 财政年份:
    2016
  • 资助金额:
    $ 49.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了